Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: A pilot study
Objectives Sleep, which comprises of rapid eye movement (REM) and non-REM stages 1–3 (N1–N3), is a natural occurring state of decreased arousal that is crucial for normal cardiovascular, immune and cognitive function. The principal sedative drugs produce electroencephalogram beta oscillations, which...
Main Authors: | Akeju, Oluwaseun, Hobbs, Lauren E., Gao, Lei, Burns, Sara M., Pavone, Kara J., Plummer, George S., Walsh, Elisa C., Houle, Tim T., Kim, Seong-Eun, Bianchi, Matt T., Ellenbogen, Jeffrey M., Brown, Emery Neal |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/126436 |
Similar Items
-
Spatiotemporal Dynamics of Dexmedetomidine-Induced Electroencephalogram Oscillations
by: Akeju, Oluwaseun, et al.
Published: (2017) -
Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness
by: Akeju, Oluwaseun, et al.
Published: (2015) -
A Comparison of Propofol- and Dexmedetomidine-induced Electroencephalogram Dynamics Using Spectral and Coherence Analysis
by: Akeju, Oluwaseun, et al.
Published: (2016) -
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): Protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial
by: Shelton, Kenneth T, et al.
Published: (2020) -
Nitrous oxide-induced slow and delta oscillations
by: Pavone, Kara J., et al.
Published: (2016)